Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
1997-10-28
|
pubmed:abstractText |
Atopic asthma is characterized by chronic inflammation of the bronchial mucosa in which eosinophil- and immunoglobulin E (IgE)-dependent mechanisms are believed to be prominent. Therefore, specific proeosinophilic mediators such as interleukin (IL)-5 and essential cofactors for IgE switching in B-lymphocytes such as IL-4 could play a pivotal role in asthma. However, the exact role that individual inflammatory mediators play in the development of the disease in humans is still unknown. Using semiquantitative reverse transcriptase-polymerase chain reaction amplification in bronchial biopsies from 10 atopic asthmatics, we have tested the hypothesis that IL-4 and IL-5 mRNA expression relative to beta-actin mRNA correlates with validated indicators of disease severity. IL-4 and IL-5 mRNA copies relative to beta-actin mRNA were detected in bronchial biopsies from atopic asthmatics. The numbers of IL-5 mRNA copies relative to beta-actin mRNA correlated with disease severity assessed by the Aas asthma score (r = 0.70, p = 0.01), baseline FEV1 (r = -0.94, p = 0.001), baseline peak expiratory flow rate (r = -0.77, p = 0.01), peak expiratory flow rate variability over 2 wk (r = 0.69, p = 0.028), and the histamine PC20 (r = -0.72, p = 0.018). Conversely, the numbers of IL-4 mRNA copies relative to beta-actin mRNA did not correlate with asthma severity, but they positively correlated with total serum IgE concentrations (r = -0.90, p = 0.001). Our present results support the concept that IL-5 may determine asthma clinical expression and severity, and by inference they support the development of IL-5 targeted therapies.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1073-449X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
704-8
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:9309982-Asthma,
pubmed-meshheading:9309982-Biopsy,
pubmed-meshheading:9309982-Bronchi,
pubmed-meshheading:9309982-Case-Control Studies,
pubmed-meshheading:9309982-Forced Expiratory Volume,
pubmed-meshheading:9309982-Gene Expression,
pubmed-meshheading:9309982-Humans,
pubmed-meshheading:9309982-Hypersensitivity, Immediate,
pubmed-meshheading:9309982-Immunoglobulin E,
pubmed-meshheading:9309982-Interleukin-4,
pubmed-meshheading:9309982-Interleukin-5,
pubmed-meshheading:9309982-Mucous Membrane,
pubmed-meshheading:9309982-Peak Expiratory Flow Rate,
pubmed-meshheading:9309982-Polymerase Chain Reaction,
pubmed-meshheading:9309982-RNA, Messenger,
pubmed-meshheading:9309982-Reproducibility of Results,
pubmed-meshheading:9309982-Severity of Illness Index
|
pubmed:year |
1997
|
pubmed:articleTitle |
Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma.
|
pubmed:affiliation |
Allergy and Clinical Immunology, Imperial College School of Medicine, National Heart and Lung Institute, London, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|